IND establishes a drug-discovery collaboration
The IND announces a drug-discovery collaboration with Japanese company Daiichi Sankyo, with a focus on developing therapeutics and diagnostics for several neurodegenerative diseases.
Under the terms of the agreement, Daiichi Sankyo will provide its compound library to the IND. Together, scientists at Daiichi Sankyo and the IND will perform high-throughput compound screening and optimization. This project will leverage the drug development capabilities of Daiichi Sankyo and the expertise of world-renowned neuroscientists at UCSF.
For more details, read here.
UCSF features Dr. Prusiner and the IND–Daiichi Sankyo collaboration in a recent news story, "Private Partnerships for Public Benefit."
... Read more ...